Brought to you by 
Bayer signs latest gene editing alliance with ERS Genomics
26 May 2016
Executive Summary
On the heels of its joint venture with CRISPR Therapeutics, Bayer AG signed another gene editing alliance, this time with ERS Genomics Ltd.
Deal Industry
- Research, Analytical Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com